CRISPR-based therapies to cure viral infectious diseases

all companies
milestones

Founded 2015

Partnered 2017​

Team

Daniel Dornbusch

Kamel Khalili

Board

Vasudev Bailey

Stuart Peterson (observer)

LEAD INVESTOR
category
Infectious

Gene editing medicines that eradicate or disrupt viral genes in human patients

No items found.